we previously demonstrated that recombinant interferon alfa-2a ( ifn-alfa ) in a dose of 50 x 10 ( 6 ) u million units ( mu ) /m2 intramuscularly ( im ) three times per week has efficacy against mycosis fungoides ( mf ) and the sezary syndrome ( ss ) .
C0021734
recombinant interferon alfa-2a
C0036920
sezary syndrome